NCT05623098

Brief Summary

Clinical and animal studies have found that sepsis can lead to a serious imbalance in the gut microecology, a reduction in probiotics, a reduction in short-chain fatty acid, a reduction in bone mass, and an increase in bone destruction, maintaining the stability of microecology can be one of the effective means of bone protection. But at present, the treatment of sepsis with early supplementation of probiotics is still controversial, and dietary fiber intake has significantly changed the composition of the microbiota, it may be a safe and effective method to prevent bone loss in sepsis. Further study on it will provide reliable theoretical basis and intervention target for early, safe and effective prevention of osteoporosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
2

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Apr 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2022

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 31, 2022

Completed
3 months until next milestone

First Posted

Study publicly available on registry

November 21, 2022

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

November 21, 2022

Status Verified

November 1, 2022

Enrollment Period

2.8 years

First QC Date

August 31, 2022

Last Update Submit

November 18, 2022

Conditions

Keywords

short-chain fatty acidsepsisbone metabolism

Outcome Measures

Primary Outcomes (2)

  • The changes of bone metabolic markers β-CTX

    The venous blood was drawn daily before and after the enrollment (the first, third, seventh and fourteenth days) ,and β- CTX for comparison

    28 day

  • The changes of bone metabolic markers PINP

    28 day

Secondary Outcomes (9)

  • Changes in intestinal flora

    28 day

  • Changes in short-chain fatty acid of metabolites

    28 day

  • Abdominal symptoms (abdominal distention)

    28 day

  • Abdominal symptoms ( diarrhea incidence)

    28 day

  • The change of systemic inflammatory response index: the value of TNF-α in systemic inflammatory response

    28 day

  • +4 more secondary outcomes

Study Arms (2)

Dietary fiber was not added to enteral nutrition preparation

Dietary fiber was not added to enteral nutrition preparation

Dietary fiber was added to enteral nutrition preparation

Dietary fiber was added to enteral nutrition preparation

Dietary Supplement: dietary fiber nutrients

Interventions

dietary fiber nutrientsDIETARY_SUPPLEMENT

Whether to add nutrients containing dietary fiber

Dietary fiber was added to enteral nutrition preparation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

1\) sepsis 20163.0: infection + sequential organ failure assessment (Sofa) score ≥2 points. (rapid SOFA (qSOFA) scoring tool criteria: (1) respiratory frequency ≥22 beats/min; (2) change in state of consciousness; (3) systolic blood pressure ≤100 mm Hg) .

You may qualify if:

  • The subjects voluntarily cooperated with the study and signed the informed consent form, and could be followed up
  • Age 18-70
  • It meets the diagnostic criteria of Sepsis 2016 Sepsis 3.0 guidelines
  • After treatment, the Hemodynamics is stable and the patient is ready to start enteral nutrition support
  • Those who need tube feeding for more than 14 days because of the need of illness and can not take food by mouth

You may not qualify if:

  • People who have had osteoporosis in the past
  • Admission due to fracture
  • The shock was not corrected, and the patients were maintained with a large amount of vaso-active drugs (0.5 ug/kg/min of noradrenaline) , but could not be given enteral nutrition
  • Supplement with probiotics or prebiotics alone
  • Parturients
  • No written informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Zhujiang hospital

Guangzhou, Guangdong, 510515, China

Location

MeSH Terms

Conditions

Sepsis

Condition Hierarchy (Ancestors)

InfectionsSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief researcher

Study Record Dates

First Submitted

August 31, 2022

First Posted

November 21, 2022

Study Start

April 1, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

November 21, 2022

Record last verified: 2022-11

Locations